Drug Trial Radar · NCT06663176
Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
Last checked: Nov 19, 2026Latest source record: Mar 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Oct 16, 2024
Primary completion
Feb 5, 2028
Study completion May 5, 2028
Sponsor
- Lead sponsor
- Thirty Respiratory LimitedIndustry
- Sponsor type
- Industry
- First posted
- Oct 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1/2a, Multi-Centre, Randomised, Open-label study to assess the safety, tolerability, PK, and efficacy of RESP30X in Adult NCFB participants with confirmed high-titre respiratory PPMs.
Conditions
- Non-Cystic Fibrosis Bronchiectasis
Interventions
RESP302Drug
Nitric Oxide agent
RESP303Drug
Nitric Oxide agent
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence, intensity, causality, and seriousness of treatment-emergent adverse events (TEAEs).Time frame: 58 days
- Changes in clinical laboratory values (haematology, clinical chemistry) at each time point.Time frame: 58 days
- Changes in vital signs (blood pressure, heart rate, temperature, respiratory rate) and SpO2 at each time point.Time frame: 58 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ARENSIA Exploratory Medicine
Kyiv, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.